Frontlight ResearchEarly access
Huntington's disease trials in Argentina
2 of 3 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleStudy to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
- Where
- Buenos Aires, Caba, CABA, Mendoza
- Age
- 25 years and over
- People
- 400 worldwide
- Run by
- Skyhawk Therapeutics, Inc.
See details and how to joinNCT07378644 · EU 2025-522263-14-00 - Phase 3Taking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Buenos Aires, CABA, Ciudad de
- Age
- 21 years to 70 years
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00